Quidel | QDEL - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Abbott USD 52.06B 69M 2026-03
Agilent USD 7.12B 214M 2026-03
Avanos Medical USD 782.1M 3.9M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Bruker USD 2.46B 35.9M 2025-12
Cerus USD 64.22M 2.76M 2025-12
Charles River Laboratories USD 2.9B 265.94M 2026-03
Danaher USD 52.95B 415M 2026-03
Haemonetics USD 796.32M 115.13M 2026-03
Illumina USD 2.68B 47M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Merit Medical Systems USD 1.63B 42.42M 2026-03
Mettler Toledo International USD -41.88M 18.25M 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
Neogen USD 2.1B 2.09M 2025-12
OraSure Technologies USD 313.32M 27.5M 2026-03
Pacific Biosciences Of California USD 2.37M 2.98M 2026-03
Quidel USD 1.85B 69.1M 2026-03
Revvity USD 7.25B 125.54M 2025-12
STAAR Surgical USD 352.37M 8.18M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Waters USD 2.56B 230.55M 2025-12